Category - New Drug Applications
Glenmark Pharmaceuticals Announces the Company’s First NDA for Ryaltris for Patients with Seasonal Allergic Rhinitis
Agile Therapeutics, Inc. Provides Regulatory Update on Twirla (AG200-15) for the Prevention of Pregnancy
Braeburn Resubmits New Drug Application for CAM2038 for Opioid Use Disorder
AcelRx Announces FDA Acceptance of NDA for DSUVIA
FDA to Review Zynquista (sotagliflozin) as Potential Treatment for Type 1 Diabetes
INSYS Therapeutics Confirms Outcome of FDA Advisory Committee Meeting on Buprenorphine Sublingual Spray
Aerie Pharmaceuticals Submits NDA to FDA for Roclatan (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005%
SIGA Technologies Announces Favorable Outcome of Advisory Committee In Support of TPOXX